Skip to main navigation
Skip to search
Skip to main content
Pure University (For Demo Only) Home
Help & FAQ
English
中文
Home
Profiles
Research units
Research output
Equipment
Datasets
Activities
Prizes
Impacts
Projects
Press/Media
Search by expertise, name or affiliation
Denaturalizing transparency in drug regulation
Matthew Herder
Psychology
Research output
:
Contribution to journal
›
Article
›
peer-review
7
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Denaturalizing transparency in drug regulation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Drug Regulation
100%
Alternative Conceptions
40%
Drug Development
20%
Policy Initiatives
20%
Clinical Trials
20%
Clinical Trial Data
20%
Pharmaceutical Drugs
20%
Collaborative Relationship
20%
Early Years
20%
Fraud
20%
Insider
20%
Regulatory Decision Making
20%
Drug Research
20%
Government Transparency
20%
Information Disclosure
20%
Drug Adulteration
20%
Unwanted Behaviors
20%
Physician-industry Relationships
20%
Medicine and Dentistry
Clinical Trial
100%
Conception
100%
Decision Making
50%
Fraud
50%
Neuroscience
Decision-Making
100%
Behavior (Neuroscience)
100%
Psychology
Disclosure
100%
Decision Making
50%
Economics, Econometrics and Finance
Industry
100%
Research and Development
50%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%